Ocrevus rapidly depletes immune B-cells in people with MS, but ongoing treatment also leads to changes in immune T-cells, a study found.

New data suggest the potential of the CAR T-cell therapy obe-cel as a definitive treatment for R/R B-cell acute lymphoblastic ...

A Northwestern Medicine study has uncovered new insights that may aid in understanding and potentially treating one of the ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric patients with B-cell acute lymphoblastic leukemia (B ...

The body has an intricate system to defend against infections where each type of immune cell plays a distinct role. Now, a ...

Research conducted on mice has identified that the rapid response of a specific type of defense cell is essential for controlling Oropouche virus infections and preventing serious neurological damage.

In an otherwise treatment-refractory population, the combination shows favorable overall response rates in patients with ...

Results from the Phase II EPCORE NHL-6 trial showed that Genmab’s and AbbVie’s Epkinly (epcoritamab) demonstrated encouraging ...

The drug, Yescarta, is reportedly sold in Singapore for about S$480,700. Read more at straitstimes.com. Read more at ...